Catalyst Pharmaceuticals Inc (CPRX) stock has gained 3.49% over the past week and gets a Bullish rating from InvestorsObserver's Sentiment Indicator.
What is Stock Sentiment?
Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.
As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.
Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor.
InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon.
The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.
What's Happening With CPRX Stock Today?
Catalyst Pharmaceuticals Inc (CPRX) stock is down -2.87% while the S&P 500 is unchanged 0% as of 2:22 PM on Tuesday, Dec 1. CPRX is lower by -$0.11 from the previous closing price of $3.66 on volume of 1,173,918 shares. Over the past year the S&P 500 has gained 16.84% while CPRX is lower by -23.28%. CPRX earned $0.67 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 5.29.
To see InvestorsObserver's Sentiment Score for Catalyst Pharmaceuticals Inc click here.
More About Catalyst Pharmaceuticals Inc
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with lambert-eaton myasthenic syndrome.
Click Here to get the full Stock Score Report on Catalyst Pharmaceuticals Inc (CPRX) Stock.
